Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

MAY 01, 2013 - TheStreet

A Must Read - Share

Johnson & Johnson's Stock Looks Too Healthy

NEW YORK (TheStreet) -- While I have always liked health-care giant Johnson & Johnson , it's hard to recommend taking a position at these levels. The stock is already up more than 22% on the year and trading at a price/earnings ratio that is more than twice that of rival Abbott Laboratories and eight points higher than Pfizer . Although Johnson & Johnson remains an undisputed force in health care, this has not been a flawless operation. The company's reputation is still in "recovery" after having dealt with some bad PR related to product recalls. Now, there are new worries about ... Read More

Tags: Johnson & Johnson's Stock Looks Too Healthy,  Pfizer Latest News